DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets has announced the addition of the \"Nanotechnology Drug Delivery Market in the US 2012-2016\" report to their offering. <\/p>\n
One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. <\/p>\n
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Over the years, the research activities in healthcare have changed significantly. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. A customized treatment is based on the genetic as well as medical profile of a patient. Increasing knowledge about the molecular causes of diseases is increasing the demand for more targeted and effective nanotechnology-enabled drug delivery therapies.'' <\/p>\n
According to the report, one of the most important applications of nanotechnology in medicine currently being developed involves employing nanoparticles to deliver drugs to specific types of cells (such as cancer cells). Nanotechnology drug delivery helps in delivering drugs directly to diseased cells, which allows direct treatment of those cells. This technique helps to avoid damage to healthy cells within the human body. Hence, drug delivery technology helps to increase the overall market success of a particular drug. <\/p>\n
Further, the report states that one of the main challenges is the increasing safety concerns. Studies have revealed that the use of various nanomaterials may cause a variety of toxic effects. Lack of FDA directives is another major factor hampering the growth of the Nanotechnology Drug Delivery market in the US. <\/p>\n
Companies Mentioned <\/p>\n
- Alkermes plc <\/p>\n
- Celgene Corp. <\/p>\n
- Novartis AG <\/p>\n
<\/p>\n
Follow this link: <\/p>\n
Research and Markets: The Nanotechnology Drug Delivery Market in the US to Grow At A CAGR Of 84.79 Percent over the ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the \"Nanotechnology Drug Delivery Market in the US 2012-2016\" report to their offering. Continue reading